Jaguar Health (NASDAQ:JAGX) Stock Passes Below 200-Day Moving Average – Here’s Why

Jaguar Health, Inc. (NASDAQ:JAGX)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $22.45 and traded as low as $4.29. Jaguar Health shares last traded at $4.37, with a volume of 29,507 shares.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on shares of Jaguar Health in a research note on Friday, March 28th. They set a “sell” rating on the stock.

Jaguar Health Stock Down 4.0 %

The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36. The company has a fifty day moving average price of $14.87 and a two-hundred day moving average price of $22.45.

Hedge Funds Weigh In On Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC purchased a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health as of its most recent SEC filing. 12.04% of the stock is owned by hedge funds and other institutional investors.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.